US FDA approval for Warner Chilcott's new oral contraceptive

The US Food and Drug Administration have approved the use of a new oral contraceptive from Ireland-based drugmaker Warner Chilcott (Nasdaq: WCRX).

Lo Minastrin Fe (norethindrone acetate and ethinyl estradiol chewable tablets, ethinyl estradiol tablets and ferrous fumarate tablets) are approved for the prevention of pregnancy in women of reproductive age.

Roger Boissonneault, president and chief executive of Warner Chilcott, said: “We are pleased to announce the approval of Lo Minastrin Fe, which marks the fifth FDA-approved product for the company since the beginning of 2013.”